Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCHW) FCF Margin (2022 - 2025)

Historic FCF Margin for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to 10428.57%.

  • Envoy Medical's FCF Margin fell 40089300.0% to 10428.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 8235.1%, marking a year-over-year increase of 9512300.0%. This contributed to the annual value of 8412.89% for FY2024, which is 29559300.0% down from last year.
  • Envoy Medical's FCF Margin amounted to 10428.57% in Q3 2025, which was down 40089300.0% from 5719.23% recorded in Q2 2025.
  • Envoy Medical's 5-year FCF Margin high stood at 1296.25% for Q3 2023, and its period low was 12100.0% during Q4 2022.
  • In the last 4 years, Envoy Medical's FCF Margin had a median value of 8110.87% in 2025 and averaged 7752.69%.
  • As far as peak fluctuations go, Envoy Medical's FCF Margin soared by 105122200bps in 2023, and later plummeted by -77158900bps in 2024.
  • Envoy Medical's FCF Margin (Quarter) stood at 12100.0% in 2022, then rose by 3bps to 11753.68% in 2023, then rose by 8bps to 10850.0% in 2024, then grew by 4bps to 10428.57% in 2025.
  • Its FCF Margin was 10428.57% in Q3 2025, compared to 5719.23% in Q2 2025 and 8110.87% in Q1 2025.